Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 101
of 6Next
2:

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID: 16414206 [PubMed - indexed for MEDLINE]

3:

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK, Donovan DT, Woo SY.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):21-32.

PMID: 10477002 [PubMed - indexed for MEDLINE]

4:

Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases.

Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC.

Arch Otolaryngol Head Neck Surg. 1997 Jan;123(1):34-40.

PMID: 9006501 [PubMed - indexed for MEDLINE]

5:

Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.

Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y.

J Nucl Med. 2003 Feb;44(2):198-206.

PMID: 12571209 [PubMed - indexed for MEDLINE]

6:

[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer]

Hasbini A, Le Péchoux C, Roche B, Pignol JP, Zelek L, Abdulkarim B, Arriagada R, Guinebretière JM, Tardivon A, Spielmann M, Habrand JL.

Cancer Radiother. 2000 Jul-Aug;4(4):265-73. French.

PMID: 10994390 [PubMed - indexed for MEDLINE]

7:

Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.

Frilling A, Weber F, Saner F, Bockisch A, Hofmann M, Mueller-Brand J, Broelsch CE.

Surgery. 2006 Dec;140(6):968-76; discussion 976-7.

PMID: 17188146 [PubMed - indexed for MEDLINE]

8:

Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.

Kim JS, Kim JS, Kim SY, Kim KH, Cho MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. Review.

PMID: 12654434 [PubMed - indexed for MEDLINE]

9:

Management of nonsinonasal neuroendocrine carcinomas of the head and neck.

Barker JL Jr, Glisson BS, Garden AS, El-Naggar AK, Morrison WH, Ang KK, Chao KS, Clayman G, Rosenthal DI.

Cancer. 2003 Dec 1;98(11):2322-8.

PMID: 14635065 [PubMed - indexed for MEDLINE]

10:

Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.

Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.

Head Neck. 2004 May;26(5):389-95.

PMID: 15122654 [PubMed - indexed for MEDLINE]

11:

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.

Dobrowsky W, Naudé J, Widder J, Dobrowsky E, Millesi W, Pavelka R, Grasl C, Reichel M.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):803-6.

PMID: 9845100 [PubMed - indexed for MEDLINE]

12:

Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.

Kuhnt T, Mueller AC, Pelz T, Haensgen G, Bloching M, Koesling S, Schubert J, Dunst J.

J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. Epub 2005 Nov 1.

PMID: 16088405 [PubMed - indexed for MEDLINE]

13:

Neuroendocrine carcinoma of the stomach with peripancreatic lymph node metastases successfully treated with pancreaticoduodenectomy.

Ma J, Kimura W, Takeshita A, Hirai I, Moriya T, Mizutani M.

Hepatogastroenterology. 2007 Oct-Nov;54(79):1945-50.

PMID: 18251134 [PubMed - indexed for MEDLINE]

15:

[Neuroendocrine primary cutaneous carcinoma. Therapeutic aspects in 13 patients]

Bedane C, Clavère P, Lavignac C, Labrousse F, Olivier JP, Bonnetbalnc JM.

Ann Dermatol Venereol. 1996;123(8):443-6. French.

PMID: 9033711 [PubMed - indexed for MEDLINE]

16:

Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.

Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.

Strahlenther Onkol. 2003 Oct;179(10):673-81.

PMID: 14566475 [PubMed - indexed for MEDLINE]

17:

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

Zwitter M, Kovac V, Smrdel U, Strojan P.

J Thorac Oncol. 2006 Sep;1(7):662-6.

PMID: 17409933 [PubMed - indexed for MEDLINE]

18:

[Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas]

Stuschke M, Budach V, Dinges S, Jahnke K, Budach W, Heselmann I, Unger A, Stüben G, Sack H.

Strahlenther Onkol. 1994 Dec;170(12):689-99. German.

PMID: 7817270 [PubMed - indexed for MEDLINE]

19:

Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?

Ballo MT, Strom EA, Prost H, Singletary SE, Theriault RL, Buchholz TA, McNeese MD.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):105-12.

PMID: 10219802 [PubMed - indexed for MEDLINE]

20:

Clinical results of unconventional fractionation radiotherapy in central nervous system tumors.

Botturi M, Fariselli L.

Tumori. 1998 Mar-Apr;84(2):176-87. Review.

PMID: 9620243 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 101
of 6Next